All In MedTech

Device Trial Radar · NCT03882671

Development of a Minimally Invasive Seizure Gauge

Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jan 1, 2019

Primary completion

Dec 31, 2023

Study completion Dec 31, 2023

Sponsor

Lead sponsor
Seer Medical Pty LtdNot on our public-company list
Sponsor type
Industry
First posted
Mar 20, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The researchers are trying to assess changes in physiological signals before and during seizures.

Conditions

  • Epilepsy

Interventions

  • EpiTel EpilogDevice

    EEG recording device

  • Empatica E4Device

    PPG, sweat level, temperature and accelerometry recording device

  • GENEActivDevice

    Temperature, light level and accelerometry recording device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Multimodal Assessment of Physiological Signals During Seizure Events Measurable with Wearable SensorsTime frame: 2-7 days approximately

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seer Medical

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.